11 pending office actions • 7 clients
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18294823 | METHODS OF TREATING MIGRAINE WITH MNK INHIBITORS | BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | RICCI, CRAIG D | 1611 | Non-Final OA | Feb 02, 2024 |
| 18466908 | METHODS OF USING EHMT2 INHIBITORS IN IMMUNOTHERAPIES | Epizyme, Inc. | BAHTA, MEDHANIT W | 1692 | Non-Final OA | Sep 14, 2023 |
| 18271330 | ANTI-INFECTIVE BICYCLIC PEPTIDE LIGANDS | UNITED KINGDOM RESEARCH AND INNOVATION | BOWLES, DAVID PAUL | 1654 | Non-Final OA | Jul 07, 2023 |
| 18271333 | ANTI-INFECTIVE BICYCLIC PEPTIDE LIGANDS | UNITED KINGDOM RESEARCH AND INNOVATION | VARADARAJ, ARCHANA | 1658 | Non-Final OA | Jul 07, 2023 |
| 18271344 | ANTI-INFECTIVE BICYCLIC PEPTIDE LIGANDS | UNITED KINGDOM RESEARCH AND INNOVATION | D' AMBROSIO, THEA | 1654 | Non-Final OA | Jul 07, 2023 |
| 18343982 | USP1 INHIBITORS AND USES THEREOF | Zentaur Therapeutics Usa Inc. | MOTEVALLI, OROD | 1628 | Non-Final OA | Jun 29, 2023 |
| 18209783 | METHODS AND COMPOSITIONS FOR DAILY OPHTHALMIC ADMINISTRATION OF PHENTOLAMINE TO IMPROVE VISUAL PERFORMANCE | Opus Genetics, Inc. | MOU, LIYUAN | 1628 | Non-Final OA | Jun 14, 2023 |
| 18319052 | LIVER DE-TARGETED RECOMBINANT AAV CAPSID PROTEINS | Homology Medicines, Inc. | BARRERA, IMMACULADA | 1671 | Non-Final OA | May 17, 2023 |
| 18188721 | COMBINATION THERAPY FOR TREATING CANCER | Epizyme, Inc. | XIAO, YAN | 1642 | Non-Final OA | Mar 23, 2023 |
| 18182001 | BIDIRECTIONAL DUAL PROMOTER EXPRESSION VECTORS AND USES THEREOF | Homology Medicines, Inc. | THUESON, HANNA MARIE | 1638 | Non-Final OA | Mar 10, 2023 |
| 17960501 | METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING RETINAL DAMAGE IN GLAUCOMA | The Brigham And Women'S Hospital, Inc. | CRAIGO, BAHAR ALAWI | 1699 | Non-Final OA | Oct 05, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial